Two Sigma Securities, LLC Contrafect Corp Transaction History

Two Sigma Securities, LLC

  • $8.19 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$0.09 - $0.19 $1,210 - $2,555
-13,449 Reduced 25.41%
39,476 $3,000
Q3 2022

Nov 14, 2022
BUY
$0.18 - $3.51 $9,526 - $185,766
52,925 New
52,925 $9,000
Q1 2022

May 16, 2022
SELL
$2.26 - $3.84 $47,735 - $81,108
-21,122 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$2.47 - $4.14 $52,171 - $87,445
21,122 New
21,122 $56,000

Others Institutions Holding CFRX

# of Institutions
2
Shares Held
49.2K
Call Options Held
0
Put Options Held
0
View Full List

About CONTRAFECT Corp

CFRX Quotes by TradingView
  • Ticker CFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,332,700
  • Market Cap $1.18M
  • Description
  • ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus...
More about CFRX
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email